[Treatment of "collagen and autoimmune" diseases (author's transl)].
D000293:Adolescent; D000328:Adult; D062365:Aminobenzoates / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003882:Dermatomyositis / Q000188:drug therapy*; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009640:Norethindrone / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D011278:Pregnanes / Q000627:therapeutic use; D012594:Scleroderma, Localized / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D062365:Aminobenzoates; D003911:Dextrans; D011278:Pregnanes; D002738:Chloroquine; D003520:Cyclophosphamide; D010396:Penicillamine; D001379:Azathioprine; D009640:Norethindrone; D007213:Indomethacin; D008727:Methotrexate
Zur Therapie sogenannter Kollagen- und Autoimmunkrankheiten.